Chemed Co. (NYSE:CHE) Shares Bought by McAdam LLC
McAdam LLC grew its stake in shares of Chemed Co. (NYSE:CHE) by 5.2% in the fourth quarter, HoldingsChannel reports. The fund owned 830 shares of the company’s stock after buying an additional 41 shares during the quarter. McAdam LLC’s holdings in Chemed were worth $365,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Harvest Fund Management Co. Ltd increased its position in Chemed by 152.9% during the 2nd quarter. Harvest Fund Management Co. Ltd now owns 177 shares of the company’s stock worth $64,000 after purchasing an additional 107 shares in the last quarter. Exane Derivatives bought a new stake in Chemed in the fourth quarter valued at about $89,000. Whittier Trust Co. increased its holdings in Chemed by 71.1% in the third quarter. Whittier Trust Co. now owns 325 shares of the company’s stock valued at $136,000 after purchasing an additional 135 shares during the last quarter. Private Advisor Group LLC bought a new stake in Chemed in the second quarter valued at about $201,000. Finally, Balasa Dinverno & Foltz LLC bought a new stake in Chemed in the third quarter valued at about $213,000. 88.81% of the stock is owned by hedge funds and other institutional investors.
In other Chemed news, Director Frank E. Wood sold 1,200 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $445.17, for a total value of $534,204.00. Following the completion of the transaction, the director now directly owns 1,457 shares of the company’s stock, valued at $648,612.69. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Michael D. Witzeman sold 2,500 shares of the company’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $432.69, for a total value of $1,081,725.00. Over the last three months, insiders sold 8,660 shares of company stock valued at $3,679,279. Insiders own 3.96% of the company’s stock.
Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $3.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.31 by $0.15. Chemed had a return on equity of 35.06% and a net margin of 11.14%. The firm had revenue of $480.61 million during the quarter, compared to analysts’ expectations of $478.89 million. During the same period in the previous year, the firm earned $3.07 earnings per share. The company’s revenue was up 8.2% on a year-over-year basis. As a group, sell-side analysts expect that Chemed Co. will post 13.47 EPS for the current year.
A number of research firms recently commented on CHE. Oppenheimer upped their price objective on Chemed from $440.00 to $470.00 and gave the company a “market perform” rating in a report on Monday, November 25th. ValuEngine downgraded Chemed from a “hold” rating to a “sell” rating in a report on Tuesday, December 3rd. Finally, JMP Securities upgraded Chemed from a “market perform” rating to an “outperform” rating and set a $490.00 price objective for the company in a report on Friday, November 1st. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $466.25.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
See Also: Market Indexes
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.